Phlebotomy Tubes Market - Dynamics , Driver and Restraint

Phlebotomy tubes are sterilized plastic or glass tubes that are used to collect blood, urine, and serum samples from patients in order to diagnose blood diseases. Phlebotomy tubes include sodium heparin tubes, serum separating tubes, vacutainer blood collection tubes, plasma separation tubes, and EDTA tubes, among others.

The Phlebotomy Tubes Market is expected to grow at a CAGR of 6.0 percent between 2020 and 2025, from USD 4.8 billion in 2020 to USD 6.4 billion in 2025. The rising frequency of infectious diseases, the rising number of accidents and trauma cases, the advent of liquid biopsy tests, and a demand for blood donations and blood transfusions are all important drivers driving the growth of this market.

BLOOD COLLECTION DEVICES Market Dynamics

Driver: Increasing chronic & lifestyle diseases

The global burden of chronic diseases is rapidly rising. Cardiovascular disease is responsible for about half of all chronic disease deaths (CVD). According to the American Heart Association, the prevalence of CVD in the United States is expected to rise from 36.9% in 2010 to 38.7% by 2020 and 40.5 percent by 2030. Obesity and diabetes are also exhibiting alarming trends, not only because they affect such a huge percentage of the population, but also because they have begun to manifest earlier in life. Lifestyle disorders are becoming more common all throughout the world, especially in developing countries.

This situation has resulted in increased health checkup adherence and the growing importance of markers for detecting illness problems, mostly through blood collection. Personal and corporate health exams are becoming increasingly popular for employee well-being. Because blood tests are the major means of identifying various disorders, this will be beneficial to market growth and a substantial contributor to the Phlebotomy Tubes

Market.

Restraint: High cost of automated blood collection devices

In comparison to the whole-blood collection, capital investments in automated blood collection utilizing apheresis systems are very significant for blood banks. Devices are priced between USD 45,000 and USD 55,000 on average. As a result, smaller blood banks and hospitals avoid this method of blood collection. Therapeutic apheresis is also quite expensive, as it includes the cost of disposables, which range from USD 1,500 to USD 3,000 per patient. Because of their high costs, automated blood collection items are not as widely used as manual blood collection systems in nations like China and India. The total growth of blood collection equipment is being stifled as a result of this.

The expense of giving apheresis therapy is a topic that practically everyone is concerned about. Individual apheresis treatment prices are readily known, however, they vary greatly. In the United States, for example, an apheresis technique costs around USD 2,500 per session.. The initial cost of setting up a blood cell separator ranges from USD 19,000 to USD 32,000, and disposable sets made by manufacturers will cost between USD 40 and USD 90 per treatment. The remaining costs, which range from USD 125 to USD 600 for each treatment, are made up of replacement fluids (with an average volume of 2.8 liters), such as albumin or fresh frozen plasma.

Challenge: Complexities of storage and shipping

The difficulty and expenses of storing and delivering entire blood samples are enormous. Whole blood must be utilized right away or preserved and kept under stringent temperature and environmental conditions for analysis or other applications once it is collected. If blood samples are not chilled or frozen, their characteristics begin to change within hours of collection. Because blood components decay quickly, maintaining their stability is critical; prolonged exposure to ambient temperatures can drastically alter the results of any analysis on such samples. As a result, medical organizations all around the world have developed storage, packaging, and shipping protocols.

Whole blood samples housed in specific containers, for example, should only be kept chilled for 42 days, according to the US FDA. It is understood, however, that some changes in the samples may occur throughout this time. Another governing agency, Finland's National Institute of Health and Welfare, declared that entire blood samples should only be kept refrigerated at 4° C (approximately 39° F) and should only be held for up to seven days before discarding.


Comments

Post a Comment

Popular posts from this blog

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because
Read more

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc
Read more

From 2016-2021, Automated Fare Collection System Market predicted to rise significantly

Image
  AFC is commonly used to replace paper-based public transportation tickets with electronic tickets. The AFC system is a stored value-based, contactless smart card application that may be upgraded with the mobile ticketing application. It is meant for public transportation and micro-payment activities.AFC is commonly used to collect consumption data quickly and effectively by automatically logging transactions, allowing for better service planning and optimization, variable pricing schemes, easy access to bundled services, and consumer convenience. AFC guards against the unauthorized creation and alteration of data stored on cards. It prevents you from reading one card while writing on another. It guards against card cloning.. During the projection period, the overall Automated Fare Collection System Market is expected to increase from USD 6.42 billion in 2016 to USD 11.95 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 13.2 percent. Some of the elements that are predict
Read more